Study of a Live Attenuated Chikungunya Vaccine in a Previously Epidemic Area

NCT03101111 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

34

Enrollment

INDUSTRY

Sponsor class

Conditions

Chikungunya

Interventions

BIOLOGICAL: MV-CHIK
BIOLOGICAL: MMR-vaccine

Sponsor

Themis Bioscience GmbH

Collaborators

[object Object]